Novartis News
|
The Swiss pharmaceutical company Novartis has recalled a painkiller medicine from the market: Excedrin, a migraine treatment, from sale in South Africa. This follows an earlier recall of the same medicine in the US.
|
|
The pharmaceutical company Novartis is under investigation by the European Union following the deaths of 11 patients who took the drug Gilenya.
|
|
Drug company Novartis Consumer Health, Inc. (NCH) has issued a voluntary recall on several over-the-counter (OTC) medications due to several possible problematic issues.
|
|
Silver Spring -
Finally the U.S. Food and Drug Administration has approved a pill that it says is both safe and effective for controlling tremors and other symptoms of multiple sclerosis.
|
|
With the Obama administration coming under fire for failing to deliver adequate swine flu vaccinations for the American public, Novartis announces its intention to supply 30 million more doses.
|
|
A Swiss drug company will not be helping out the poor when it comes to the swine flu, defying the World Health Organization.
|
|
Novartis, the Swiss pharmaceutical company, has launched a new version of its malaria drug. 'Coartem' is now child friendly in a cherry flavor that is hoped will be less likely to be spit out and won't be as hard to administer to children.
|
Legal wrangle by Novartis puts India's generic drugs at risk and will affect millions of patients who seek cheap AIDS Treatment.
|
apis-169957 apis-169438 apis-168535 apis-140868 apis-128708 apis-121550 apis-115621
Novartis Headlines
Swiss drugmaker Novartis reports a sharp fall in profits, due in part to manufacturing problems at a US plant and to currency moves.
 Drug maker Novartis is taking legal action in Britain to make state-run hospitals use an eye drug that costs about $1,120 per shot instead of a cheaper one that costs $95.
The pharmaceutical company Novartis is challenging the use of a cheaper alternative to its drug Lucentis for a common cause of loss of vision.
The maker's of a drug that treats age-related macular degeneration, a disease that can cause loss of sight, are taking the NHS to court to block them from using a drug that costs ten times less and is just as effective, according to tests.
|
 |
Top News
topnews-right-177722 topnews-right-177616 topnews-right-177719 topnews-right-177731 topnews-right-177718 topnews-right-177729 topnews-right-177727 topnews-right-177725
Novartis Image

Andrew Hecht
Novartis building, taken on June 12, 2006
image:104139:0::0
Novartis Blogs
|
Big Pharma company GlaxoSmithKiline has announced that it is to recall nearly 400,000 bottles of a blood pressure drug...
|
|
With various stories recently about medical issues and concerns relating to pharmaceutical manufacturers (such as...
|
|
Following on from yesterday's post about the recall of saline nasal sprays contaminated with bacteria, and my earlier...
|
|
I have posted two previous stories on this blog about the Pharma giant Novartis having to recall tablets due to...
|
|
The U.S Food and Drug Administration is warning patients about a potential mix-up between powerful prescription pain...
|
|